ValuentumAd

Official PayPal Seal

Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
May 2, 2016
Gilead: What's Your Long Term Thesis?
Image Source: Gilead. We’re starting to see some even bigger risks at Gilead – long-term ones.
Apr 29, 2016
Gilead Disappoints, Harvoni Sales Drop 16%
Image Source: Gilead. In January 2016, we had removed Gilead from the Best Ideas Newsletter portfolio, and we added steady-eddy dividend growth giant Johnson & Johnson in its place. We were starting to think we might have made a mistake … until today.
Apr 25, 2016
Dividend Increases/Decreases for the Week Ending April 22
Let's take a look at companies raising/lowering their dividends this week.
Apr 19, 2016
Domestic Pharma Drives JNJ's 1Q; Stock Hits All-Time High
Johnson & Johnson reported strong growth in its Pharmaceutical segment in the first quarter of 2016. The underlying strength allowed the firm to raise its full-year forecasts after adjusting its outlook on currency expectations for the year.
Apr 19, 2016
ETE Down 70%; IBM Poor Quality, Netflix Begins to Implode
We continue to encourage members to keep a long-term perspective on developments.
Mar 23, 2016
What Gilead’s Patent Miscue Means for Shareholders
Image Source: Gilead. Not much…right now, but we’re sleeping better at night not including shares in the newsletter portfolios.
Mar 4, 2016
Valuentum: Still Bullish on Kinder Morgan Since Mid-Teens
Valuation and conviction by the market should change the opinion of any investor.
Feb 23, 2016
Recent Add Cracker Barrel Surges Ahead; BHP Cuts
We liked what we heard in Cracker Barrel’s outlook, and the Dividend Cushion ratio again comes up big in warning about BHP’s dividend cut.
Feb 22, 2016
Key Treatment Momentum Drives Big Pharma
Let’s take a look at the recent results of some of the biggest names in Big Pharma.
Feb 12, 2016
Your Hard-Earned Money
Valuentum is releasing its February Best Ideas Newsletter early, February 12, in light of Presidents’ Day weekend.



The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.